Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Recurrent Vulvovaginal Candidiasis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing SHR8008 to fluconazole for recurrent vulvovaginal candidiasis to evaluate efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Drugs mentioned

• Fluconazole (Fluconazole)
• SHR8008

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Recurrent Vulvovaginal Candidiasis | Phase 3 | Status: UNKNOWN